Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 0.7% – Should You Sell?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s share price dropped 0.7% during mid-day trading on Friday . The stock traded as low as $14.89 and last traded at $14.89. Approximately 545 shares were traded during trading, a decline of 81% from the average daily volume of 2,856 shares. The stock had previously closed at $15.00.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on TLX. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group assumed coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 target price for the company.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.